Oakbrook Investments’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Oakbrook Investments’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,856	Closed	-$316K	–	635
2017 Q4	$316K	Buy	5,856 +120	+2%	+$6.57K	0.02%	453
2017 Q3	$327K	Buy	5,736 +1,100	+24%	+$64.4K	0.02%	424
2017 Q2	$279K	Sell	4,636 -712	-13%	-$40.5K	0.02%	441
2017 Q1	$291K	Buy	+5,348	New	+$263K	0.02%	438

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Oakbrook Investments's BIVV Position: Q1 2018 in Review

Oakbrook Investments sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 5,856 shares — an estimated $316K sold.

Oakbrook Investments first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $327K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Oakbrook Investments reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Oakbrook Investments sold 5,856 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $316K.
Oakbrook Investments first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Oakbrook Investments's Bioverativ Inc. Common Stock position peaked at $327K in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Oakbrook Investments's 13F filing for Q1 2018, filed 18 Apr 2018.